Skip to main content

Cancer Screening in Older Adults

  • Chapter
  • First Online:

This chapter focuses on the special issues that need to be considered when making decisions to screen older persons for cancer. Specifically, while there is substantial evidence that screening for colorectal, breast, and cervical cancer reduces cancer mortality among persons in their 50s and 60s [1–6], few screening trials included persons over age 70. Therefore, clinicians must assess whether to extrapolate results from screening trials to their older patients. To determine the appropriateness of this extrapolation, clinicians need to know whether there are differences in the behavior of cancers in older people that change the benefit of early detection and treatment; whether there are differences in the accuracy of screening tests in older people that make the tests more or less likely to miss cancer; and whether there are differences among older individuals that alter the likelihood of receiving benefit versus harm from cancer screening [7]. The need to individualize cancer screening decisions is especially important for older persons, because individuals become increasingly unique in their particular combination of health, life expectancy, and values with advancing age.

This is a preview of subscription content, log in via an institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. U.S. Preventive Services Task Force. Screening for colorectal cancer: U.S. Preventive Services Task Force Recommendation Statement. Ann Intern Med 2008;149:627–37.

    Google Scholar 

  2. Smith RA, Cokkinides V, Eyre HJ. Cancer screening in the United States, 2007: A review of current guidelines, practices, and prospects. CA Cancer J Clin 2007;57:90–104.

    Article  PubMed  CAS  Google Scholar 

  3. U.S. Preventive Services Task Force. Screening for breast cancer: Recommendations and rationale. Ann Intern Med 2002;137:344–6.

    Google Scholar 

  4. American Geriatrics Society Clinical Practice Committee. Breast cancer screening in older women. J Am Geriatr Soc 2000;48:842–4.

    Google Scholar 

  5. U.S. Preventive Services Task Force. Screening for cervical cancer. http://www.ahrq.gov/clinic/3rduspstf/cervcan/cervcanrr.htm. Accessed Apr. 28, 2008.

  6. American Geriatrics Society. Screening for cervical cancer in older women. J Am Geriatr Soc 2001;49:655–7.

    Google Scholar 

  7. Walter LC, Lewis CL, Barton MB. Screening for colorectal, breast, and cervical cancer in the elderly: A review of the evidence. Am J Med 2005;118:1078–86.

    Article  PubMed  Google Scholar 

  8. Walter LC, Covinsky KE. Cancer screening in elderly patients: A framework for individualized decision making. J Am Med Assoc 2001;285:2750–6.

    Article  CAS  Google Scholar 

  9. National Center for Health Statistics. Life Tables of the United States, 2001. Available at http://www.cdc.gov/nchs/data/dvs/lt2001.pdf. Accessed Apr. 28, 2008.

  10. Lee SJ, Lindquist K, Segal MR, Covinsky KE. Development and validation of a prognostic index for 4-year mortality in older adults. J Am Med Assoc 2006;295:801–8.

    Article  CAS  Google Scholar 

  11. Walsh JME, Terdiman JP. Colorectal cancer screening: Scientific review. J Am Med Assoc 2003;289:1288–96.

    Article  Google Scholar 

  12. Pignone M, Rich M, Teutsch SM, et al. Screening for colorectal cancer in adults at average risk: A summary of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2002;137:132–41.

    PubMed  Google Scholar 

  13. Hardcastle JD, Chamberlain JO, Robinson MH, et al. Randomised controlled trial of faecal-occult blood screening for colorectal cancer. Lancet 1996;348:1472–7.

    Article  PubMed  CAS  Google Scholar 

  14. Kronborg O, Fenger C, Olsen J, et al. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996;348:1467–71.

    Article  PubMed  CAS  Google Scholar 

  15. Mandel JS, Bond JH, Church TR, et al. Reducing mortality from colorectal cancer by screening for fecal occult blood. N Engl J Med 1993;328:1365–71.

    Article  PubMed  CAS  Google Scholar 

  16. Selby JV, Friedman GD, Quesenberry CP, Weiss NS. A case-control study of screening sigmoidoscopy and mortality from colorectal cancer. N Engl J Med 1992;326:653–7.

    Article  PubMed  CAS  Google Scholar 

  17. Muller AD, Sonnenberg A. Protection by endoscopy against death from colorectal cancer: A case-control study among veterans. Arch Intern Med 1995;155:1741–8.

    Article  PubMed  CAS  Google Scholar 

  18. Levin B, Lieberman DA, McFarland B, et al. Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: A joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. CA Cancer J Clin 2008;58:130–60.

    Article  PubMed  Google Scholar 

  19. Lieberman DA, Weiss DG, Bond JH, et al. Use of colonoscopy to screen asymptomatic adults for colorectal cancer. N Engl J Med 2000;343:162–8.

    Article  PubMed  CAS  Google Scholar 

  20. Stryker SJ, Wolff BG, Culp CE, et al. Natural history of untreated colonic polyps. Gastroenterology 1987;93:1009–13.

    PubMed  CAS  Google Scholar 

  21. Robinson MHE, Hardcastle JD, Moss SM, et al. The risks of screening: Data from the Nottingham randomized controlled trial of faecal occult blood screening for colorectal cancer. Gut 1999;45:588–92.

    Article  PubMed  CAS  Google Scholar 

  22. Parker MA, Robinson MHE, Scholefield JH, Hardcastle JD. Psychiatric morbidity and screening for colorectal cancer. J Med Screen 2002;9:7–10.

    Article  PubMed  CAS  Google Scholar 

  23. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001;15:1091–7.

    Article  Google Scholar 

  24. Imperiale TF, Wagner DR, Lin CY, et al. Using risk for advanced proximal colonic neoplasia to tailor endoscopic screening for colorectal cancer. Ann Intern Med 2003;139:959–65.

    PubMed  Google Scholar 

  25. Ransohoff DF, Lang CA. Screening for colorectal cancer with fecal occult blood test: A background paper. Ann Intern Med 1997;126:811–22.

    PubMed  CAS  Google Scholar 

  26. Tabar L, Vitak B, Chen H, et al. The Swedish Two-County Trial twenty years later. Radiol Clin N Am 2000;38:625–51.

    Article  PubMed  CAS  Google Scholar 

  27. Thomas DB, Gao DL, Ray RM, et al. Randomized trial of breast self-examination in Shanghai: Final results. J Natl Cancer Inst 2002;94:1445–57.

    Article  PubMed  Google Scholar 

  28. Welch HG, Fisher ES. Diagnostic testing following screening mammography in the elderly. J Natl Cancer Inst 1998;90:1389–92.

    Article  PubMed  CAS  Google Scholar 

  29. Bobo JK, Lee NC, Thames SF. Findings from 752081 clinical breast examinations reported to a national screening program from 1995 through 1998. J Natl Cancer Inst 2000;92:971–6.

    Article  PubMed  CAS  Google Scholar 

  30. Ernster VE, Ballard-Barbash R, Barlow WE, et al. Detection of ductal carcinoma in situ in women undergoing screening mammography. J Natl Cancer Inst 2002;94:1546–54.

    Article  PubMed  Google Scholar 

  31. Welch HG, Black WC. Using autopsy series to estimate the disease “reservoir” for ductal carcinoma in situ of the breast. Ann Intern Med 1997;127:1023–8.

    PubMed  CAS  Google Scholar 

  32. Barton MB, Moore S, Polk S, et al. Increased patient concern after false-positive mammograms. J Gen Intern Med 2001;16:150–6.

    Article  PubMed  CAS  Google Scholar 

  33. Walter LC, Eng C, Covinsky KE. Screening mammography for frail older women: What are the burdens? J Gen Intern Med 2001;16:779–84.

    Article  PubMed  CAS  Google Scholar 

  34. Fletcher SW, Elmore JG. Mammographic screening for breast cancer. N Engl J Med 2003;348:1672–80.

    Article  PubMed  Google Scholar 

  35. Kimmick GG, Balducci L. Breast cancer and aging. Hematol Oncol Clin N Am 2000;14:213–33.

    Article  CAS  Google Scholar 

  36. Mandelblatt J, Saha S, Teutsch, et al. The cost-effectiveness of screening mammography beyond age 65 years: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2003;139:835–42.

    PubMed  Google Scholar 

  37. Carney PA, Miglioretti DL, Yankaskas BC, et al. Individual and combined effects of age, breast density, and hormone replacement therapy use on the accuracy of screening mammography. Ann Intern Med 2003;138:168–75.

    PubMed  Google Scholar 

  38. Oestreicher N, White E, Lehman CD, et al. Predictors of sensitivity of clinical breast examination (CBE). Breast Cancer Res Treat 2002;76:73–81.

    Article  PubMed  CAS  Google Scholar 

  39. Satariano WA, Ragland DR. The effect of comorbidity on 3-year survival of women with primary breast cancer. Ann Intern Med 1994;120:104–10.

    PubMed  CAS  Google Scholar 

  40. International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Cervical Cancer Screening Programmes. Screening for squamous cervical cancer: Duration of low risk after negative results of cervical cytology and its implication for screening policies. Br Med J 1986;293:659–64.

    Google Scholar 

  41. Sawaya GF, Grady D, Kerlikowske K, et al. The positive predictive value of cervical smears in previously screened postmenopausal women: The Heart and Estrogen/Progestin Replacement Study (HERS). Ann Intern Med 2000;133:942–50.

    PubMed  CAS  Google Scholar 

  42. Sirovich BE, Gottlieb DJ, Fisher ES. The burden of prevention: Downstream consequences of Pap smear testing in the elderly. J Med Screen 2003;10:189–95.

    Article  PubMed  CAS  Google Scholar 

  43. Mandelblatt J, Lawrence W, Yi B, et al. The balance of harms, benefits, and costs of screening for cervical cancer in older women. Arch Intern Med 2004;164:245–7.

    Article  PubMed  Google Scholar 

  44. Sawaya GF. Should routine screening Papanicolaou smears be done for women older than 65 years? Arch Intern Med 2004;164:243–5.

    Article  PubMed  Google Scholar 

  45. Sawaya GF, Sung H, Kearney KA, et al. Advancing age and cervical cancer screening and prognosis. J Am Geriatr Soc 2001;49:1499–504.

    Article  PubMed  CAS  Google Scholar 

  46. Ho CM, Chien TY, Huang SH, et al. Multivariate analysis of the prognostic factors and outcomes in early cervical cancer patients undergoing radical hysterectomy. Gynecol Oncol 2004;93:458–64.

    Article  PubMed  Google Scholar 

  47. Nanda K, McCrory DC, Myers ER, et al. Accuracy of the Papanicolaou test in screening for and follow-up of cervical cytologic abnormalities: A systematic review. Ann Intern Med 2000;132:810–9.

    PubMed  CAS  Google Scholar 

  48. Sawaya GF, Brown AD, Washington AE, et al. Current approaches to cervical-cancer screening. N Engl J Med 2001;344:1603–7.

    Article  PubMed  CAS  Google Scholar 

  49. Thompson IM, Ankerst DP, Chi C, et al. Operating characteristics of prostate-specific antigen in men with an intial PSA level of 3.0 ng/ml or lower. J Am Med Assoc 2005;294:66–70.

    Article  CAS  Google Scholar 

  50. Harris R, Lohr KN. Screening for prostate cancer: An update of the evidence for the US Preventive Services Task Force. Ann Intern Med 2002;137:917–29.

    PubMed  Google Scholar 

  51. Wilt TJ, MacDonald R, Rutks I, et al. Systematic review: Comparative effectiveness and harms of treatments for clinically localized prostate cancer. Ann Intern Med 2008;148:435–48.

    PubMed  Google Scholar 

  52. McNaughton-Collins M, Fowler FJ, Caubet JF, et al. Psychological effects of a suspicious prostate cancer screening test followed by a benign biopsy result. Am J Med 2004;117:719–25.

    Article  PubMed  Google Scholar 

  53. Albertsen PC. PSA testing: Public policy or private penchant? J Am Med Assoc 2006;296:2371–3.

    Article  CAS  Google Scholar 

  54. Bill-Axelson A, Holmberg L, Ruutu M, et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2005;352:1977–84.

    Article  PubMed  CAS  Google Scholar 

  55. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002;346:1138–44.

    Google Scholar 

  56. Porter MP, Stanford JL, Lange PH. The distribution of serum prostate-specific antigen levels among American men: Implications for prostate cancer prevalence and screening. Prostate 2006;66:1044–51.

    Article  PubMed  CAS  Google Scholar 

  57. Coley CM, Barry MJ, Fleming C, Mulley AG. Clinical guideline part 1: Early detection of prostate cancer. Ann Intern Med 1997;126:394–406.

    PubMed  CAS  Google Scholar 

  58. Sox HC. Screening for disease in older people. J Gen Intern Med 1998;13:424–5.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Louise C. Walter .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Walter, L.C. (2009). Cancer Screening in Older Adults. In: Hurria, A., Balducci, L. (eds) Geriatric Oncology. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-89070-8_3

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-89070-8_3

  • Published:

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-89069-2

  • Online ISBN: 978-0-387-89070-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics